Dianthus Therapeutics to Host Conference Call and Webcast to Discuss the Interim Responder Analysis Results of the Phase 3 Captivate Trial of Claseprubart in Chronic Inflammatory Demyelinating Polyneu
Go back to Dianthus Therapeutics to Host Conference Call and Webcast to Discuss the Interim Responder Analysis Results of the Phase 3 Captivate Trial of Claseprubart in Chronic Inflammatory Demyelinating Polyneu| (NASDAQ: DNTH) | Delayed: 90.21 -7.27 (7.46%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $97.48 | 52 Week High | $ | |||
| Open | $96.68 | 52 Week Low | $ | |||
| Day High | $97.55 | P/E | N/A | |||
| Day Low | $90.08 | EPS | $ | |||
| Volume | 1,613,561 | |||||
